EDIT logo

Editas Medicine (EDIT) Shareholders Equity

Annual Shareholders Equity

$349.10 M
-$11.58 M-3.21%

31 December 2023

EDIT Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$175.63 M
-$56.38 M-24.30%

30 September 2024

EDIT Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

EDIT Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-3.2%-51.3%
3 y3 years-11.3%-70.1%
5 y5 years+47.8%-16.4%

EDIT Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-37.0%at low-70.1%at low
5 y5 years-37.0%+47.8%-72.5%at low
alltimeall time-37.0%+520.0%-72.5%+311.3%

Editas Medicine Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$175.63 M(-24.3%)
June 2024
-
$232.01 M(-21.2%)
Mar 2024
-
$294.40 M(-15.7%)
Dec 2023
$349.10 M(-3.2%)
$349.10 M(-3.2%)
Sept 2023
-
$360.46 M(-9.9%)
June 2023
-
$399.92 M(+26.0%)
Mar 2023
-
$317.47 M(-12.0%)
Dec 2022
$360.68 M(-34.9%)
$360.68 M(-13.0%)
Sept 2022
-
$414.75 M(-10.9%)
June 2022
-
$465.41 M(-9.2%)
Mar 2022
-
$512.76 M(-7.4%)
Dec 2021
$553.64 M(+40.7%)
$553.64 M(-5.6%)
Sept 2021
-
$586.79 M(-4.3%)
June 2021
-
$613.36 M(-3.9%)
Mar 2021
-
$638.00 M(+62.1%)
Dec 2020
$393.59 M(+50.0%)
$393.59 M(-10.8%)
Sept 2020
-
$441.15 M(+3.4%)
June 2020
-
$426.77 M(+81.9%)
Mar 2020
-
$234.57 M(-10.6%)
DateAnnualQuarterly
Dec 2019
$262.44 M(+11.1%)
$262.44 M(+25.0%)
Sept 2019
-
$209.99 M(+8.8%)
June 2019
-
$193.06 M(-11.1%)
Mar 2019
-
$217.16 M(-8.0%)
Dec 2018
$236.16 M(+13.5%)
$236.16 M(+5.2%)
Sept 2018
-
$224.45 M(-3.0%)
June 2018
-
$231.33 M(-6.5%)
Mar 2018
-
$247.51 M(+19.0%)
Dec 2017
$208.08 M(+54.6%)
$208.08 M(+17.0%)
Sept 2017
-
$177.79 M(-3.9%)
June 2017
-
$185.00 M(-10.4%)
Mar 2017
-
$206.46 M(+53.4%)
Dec 2016
$134.61 M(-262.0%)
$134.61 M(-20.9%)
Sept 2016
-
$170.18 M(-9.2%)
June 2016
-
$187.33 M(-7.0%)
Mar 2016
-
$201.36 M(-342.3%)
Dec 2015
-$83.11 M(+443.5%)
-$83.11 M(-165.1%)
Sept 2015
-
$127.62 M(-934.5%)
Dec 2014
-$15.29 M(+767.4%)
-$15.29 M
Dec 2013
-$1.76 M
-

FAQ

  • What is Editas Medicine annual stockholders equity?
  • What is the all time high annual shareholders equity for Editas Medicine?
  • What is Editas Medicine annual shareholders equity year-on-year change?
  • What is Editas Medicine quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Editas Medicine?
  • What is Editas Medicine quarterly shareholders equity year-on-year change?

What is Editas Medicine annual stockholders equity?

The current annual shareholders equity of EDIT is $349.10 M

What is the all time high annual shareholders equity for Editas Medicine?

Editas Medicine all-time high annual stockholders equity is $553.64 M

What is Editas Medicine annual shareholders equity year-on-year change?

Over the past year, EDIT annual stockholders equity has changed by -$11.58 M (-3.21%)

What is Editas Medicine quarterly stockholders equity?

The current quarterly shareholders equity of EDIT is $175.63 M

What is the all time high quarterly shareholders equity for Editas Medicine?

Editas Medicine all-time high quarterly stockholders equity is $638.00 M

What is Editas Medicine quarterly shareholders equity year-on-year change?

Over the past year, EDIT quarterly stockholders equity has changed by -$184.83 M (-51.28%)